Nimotuzumab: The Cuban cancer drug that reduces the lung sequelae of COVID-19
When on August 25, Doctor of Science Tania Crombet Ramos presented to the country's leadership part of the partial results of the use of the humanized monoclonal antibody Nimotuzumab, in…
Comments Off on Nimotuzumab: The Cuban cancer drug that reduces the lung sequelae of COVID-19
9 November 2021 9:13 AM